[{"Assets_0_Q2_USD":1063675000.0,"CommonStockSharesOutstanding_0_Q2_shares":52449036.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":61680000.0,"NetIncomeLoss_1_Q2_USD":32727000.0,"NetIncomeLoss_2_Q2_USD":51067000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":52385590.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":52361149.0,"StockholdersEquity_0_Q2_USD":522904000.0,"EarningsPerShareBasic_1_Q2_USD":0.62,"EarningsPerShareBasic_2_Q2_USD":0.98,"Ticker":"SUPN","CIK":"1356576","name":"SUPERNUS PHARMACEUTICALS, INC.","OfficialName":"Supernus Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1557812380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190809"}]